⌘K

16:39:24·165d

SECFilingvia Quantisnow

SEC Form 8-K filed by Crinetics Pharmaceuticals Inc.

ByQuantisnow·Wall Street's wire, on your screen.

CRNX· Crinetics Pharmaceuticals Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Okey Stephanie sold $246,143 worth of shares (6,900 units at $35.67) as part of a pre-agreed trading plan, decreasing direct ownership by 52% to 6,400 units (SEC Form 4)
Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
Crinetics and Leading Patient Groups Launch 'Everyday Advocacy' Initiative to Empower People Across Endocrine Disease Communities
President & CEO Struthers Richard Scott gifted 968,800 shares and received a gift of 968,800 shares (SEC Form 4)

SEC Form 8-K filed by Crinetics Pharmaceuticals Inc. | Quantisnow